5mg Serlopitant Tablets

DRUG2 trials

Sponsors

Vyne Therapeutics Inc.

Conditions

Prurigo NodularisPruritus

Phase 3

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

CompletedNCT03546816

Vyne Therapeutics Inc.Prurigo Nodularis, Pruritus

Start: 2018-05-02End: 2020-02-14Updated: 2021-05-20

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

CompletedNCT03677401

Vyne Therapeutics Inc.Prurigo Nodularis, Pruritus

Start: 2018-08-29End: 2020-02-06Updated: 2021-05-20